GL1X · GenesisL1 explorer

Research workbench

The crystal structure of phosphoribosylglycinamide formyltransferase from campylobacter jejuni subsp. jejuni nctc 11168

Analyse The crystal structure of phosphoribosylglycinamide formyltransferase from… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5CJJ
Type
protein
Length
377 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphoribosylglycinamide formyltransferase
EC
2.1.2.2
UniProt
Q0PBV2
Ligands
SO4, CL
Pockets
4 · best druggability 0.61

Structure

x-ray diffraction · 2 distinct chains · 35% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphoribosylglycinamide formyltransferase (EC 2.1.2.2)protein18735% helix, 24% strandQ0PBV2
BPhosphoribosylglycinamide formyltransferase (EC 2.1.2.2)protein19035% helix, 26% strandQ0PBV2

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 2 copies · chains B
  • CL · Chloride ion · ion · chains A
  • GOL · Glycerol · additive · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12990.610.7941SO4
22590.590.7929CL
3810.340.7514empty
4620.280.7317empty

Interfaces

1 interface between chains.

  • A–B · 650 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 modified (engineered).

Compared structures

  • 5CJJ · The crystal structure of phosphoribosylglycinamide formyltransferase from Campylobacter… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.